Related Experiment Video

Updated: Jun 20, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis

Giulia Fontemaggi1, Stefania Dell'Orso, Daniela Trisciuoglio

  • 1Translational Oncogenomics Unit, Regina Elena Cancer Institute, Rome, Italy.

Nature Structural & Molecular Biology
|September 29, 2009
PubMed

Insights

Mutant p53 proteins drive tumor growth by increasing ID4 expression, which promotes new blood vessel formation in cancer. This discovery reveals a new molecular pathway in tumor angiogenesis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • ID4 (inhibitor of DNA binding 4) is a key regulator in cell processes like proliferation, differentiation, and tumorigenesis.
  • ID proteins act as dominant-negative regulators of basic helix-loop-helix transcription factors.

Purpose of the Study:

  • To investigate the role of ID4 in cancer, particularly its connection to mutant p53.
  • To elucidate the molecular mechanisms by which mutant p53 influences ID4 expression and tumor angiogenesis.

Main Methods:

  • Identified ID4 as a transcriptional target of specific gain-of-function p53 mutants (R175H, R273H, R280K).
  • Assessed the impact of mutant p53 depletion on ID4 expression in tumor cells.
  • Analyzed the mutant p53-E2F1 complex binding to the ID4 promoter.
  • Investigated ID4 protein interaction with mRNAs of pro-angiogenic factors IL8 and GRO-alpha.

Main Results:

  • Depletion of mutant p53 significantly reduced ID4 expression in proliferating tumor cells.
  • The mutant p53-E2F1 complex directly binds to the ID4 promoter, enhancing its expression.
  • ID4 protein stabilizes IL8 and GRO-alpha mRNAs, increasing the angiogenic potential of cancer cells.
  • Established a transcriptional axis involving mutant p53, E2F1, and ID4.

Conclusions:

  • Mutant p53 promotes tumor angiogenesis through the transcriptional regulation of ID4.
  • The mutant p53-E2F1-ID4 axis represents a novel molecular mechanism contributing to tumor neovascularization.
  • Targeting this pathway could offer new therapeutic strategies for cancer treatment.

More Related Videos

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...